Könyvtár

Az alábbi linkekre kattintva láthatja a publikációkat. (A csoportok nem feltétlenül tartalmazzák az összes elérhető cikket az egyes területekről.)

» Klinikai fejlesztés
» A terápiás döntés változása (Decision Impact)
» Neoadjuváns terápia
» Platform technológia
» A vizsgálat fejlesztése
» További Oncotype DX tesztel kapcsolatos cikkek

Klinikai fejlesztés

» A-Multigene-Assay-to-Predict-Recurrence-of-Tamoxifen-Treated-Node-Negative-Breast-Cancer

» A Population-Based Study of Tumor Gene Expression and Risk of Breast Cancer Death Among Lymph Node-Negative Patients

» Gene Expression and Benefit of Chemotherapy in Women with Node-Negative, Estrogen Receptor-Positive Breast Cancer

» Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Breast Cancer Patients Treated with Anastrozole or Tamoxifen: A TransATAC Study

» Prognostic and Predictive Value of the 21-Gene Recurrence Score Assay in Postmenopausal, Node-Positive, Estrogen Receptor-Positive Breast Cancer

A terápiás döntés változása

» Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20.

» Impact of a Commercial Reference Laboratory Test Recurrence Score on Decision Making in Early-Stage Breast Cancer

» Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection.

» Physician Survey of the Effect of the 21-Gene Recurrence Score Assay Results on Treatment Recommendations for Patients With Lymph Node–Positive, Estrogen Receptor–Positive Breast Cancer

Neoadjuváns terápia

» Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women with Locally Advanced Breast Cancer

Platform technológia

» Analytical Validation of the Oncotype DX Genomic Diagnostic Test Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor-Positive Breast Cancer

» Biomarker discovery for colon cancer using a 761 gene RT-PCR assay

» Measurement of Gene Expression in Archival Paraffin-Embedded Tissues

A vizsgálat fejlesztése

» Development and Clinical Utility of a 21-Gene Recurrence Score Prognostic Assay in Patients with Early Breast Cancer Treated with Tamoxifen

» Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy

» Tumor Gene Expression and Prognosis in Breast Cancer Patients with 10 or More Positive Lymph Nodes

További Oncotype DX tesztel kapcsolatos cikkek

» Adjuvant Chemotherapy for Patients with Estrogen Receptor-Positive Breast Cancer

» American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

» Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials

» Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory

» Problems and Solutions in the Evaluation of Hormone Receptors in Breast Cancer

» Roadmap for Developing and Validating Therapeutically Relevant Genomic Classifiers

» Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20